Survey of the effect of biotin on glycemic control and plasma lipid concentrations in type 1 diabetic patients in Kermanshah in Iran (2008-2009)

Oman Medical Journal

Volumn 28, Issue 3, 2013, Pages 195-198

  Hemmati, Mitra ^a   Babaei, Homa ^a   Abdolsalehei, Mohammadreza ^a  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Biotin; HbA1c; Serum lipid; Type one diabetes mellitus

Indexed keywords

BIOTIN; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; GLYCEMIC CONTROL; HEALTH SURVEY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; IRAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL;

EID: 84878922779     PISSN: 1999768X     EISSN: 20705204     Source Type: Journal    
DOI: 10.5001/omj.2013.53     Document Type: Article

References (26)

1. Alemzadeh R, Wyatt DT. Diabetes Mellitus in children. In Kliegman R M et al.Nelson Text Book of Pediatrics.18th Edition. Philadelphia, 2007. p. 590.1-590.19.
2. Rodríguez Meléndez R. [Importance of biotin metabolism]. Rev Invest Clin 2000 Mar-Apr;52(2):194-199.
3. Fernandez-Mejia C. Pharmacological effects of biotin. J Nutr Biochem 2005 Jul;16(7):424-427.
4. Furukawa Y. [Enhancement of glucose-induced insulin secretion and modification of glucose metabolism by biotin]. Nihon Rinsho 1999 Oct;57(10):2261-2269.
5. Yoshikawa H, Tajiri Y, Sako Y, Hashimoto T, Umeda F, Nawata H. Effects of biotin on glucotoxicity or lipotoxicity in rat pancreatic islets. Metabolism 2002 Feb;51(2):163-168.
6. Romero-Navarro G, Cabrera-Valladares G, German MS, Matschinsky FM, Velazquez A, Wang J, et al. Biotin regulation of pancreatic glucokinase and insulin in primary cultured rat islets and in biotin-deficient rats. Endocrinology 1999 Oct;140(10):4595-4600.
7. McCarty MF. High-dose biotin, an inducer of glucokinase expression, may synergize with chromium picolinate to enable a definitive nutritional therapy for type II diabetes. Med Hypotheses 1999 May;52(5):401-406.
8. Ferre T, Pujol A, Riu E, Bosch F, Valera A. Correction of diabetic alterations by glucokinase. Proc Natl Acad Sci U S A 1996 Jul;93(14):7225-7230.
9. McCarty MF. cGMP may have trophic effects on beta cell function comparable to those of cAMP, implying a role for high-dose biotin in prevention/treatment of diabetes. Med Hypotheses 2006;66(2):323-328.
10. Zhang H, Osada K, Sone H, Furukawa Y. Biotin administration improves the impaired glucose tolerance of streptozotocin-induced diabetic Wistar rats. J Nutr Sci Vitaminol (Tokyo) 1997 Jun;43(3):271-280.
11. Coggeshall JC, Hegger JP, Robson MC, Baker H. Biotin status and plasma glucose in diabetics. Ann N Y Acad Sci 1985;447:389-393.
12. Maebashi M, Mankino Y, Furukawa Y. Therapeutic evaluation of the effect of biotin on hyperglycemia in patient with NIDDM. Clin Biochem Nutr 1993;14:211-218.
13. Marshall MW, Smith BP, Lehmann RP. Dietary response of two genetically different lines of inbred rats: lipids in serum and liver. Proc Soc Exp Biol Med 1969 Sep;131(4):1271-1277.
14. Scott D. Clinical biotin deficiency (egg white injury); report of a case with some remarks on serum cholesterol. Acta Med Scand 1958 Sep;162(1):69-70.
15. Marshall MW, Kliman PG, Washington VA, Mackin JF, Weinland BT. Effects of biotin on lipids and other constituents of plasma of healthy men and women. Artery 1980;7(4):330-351.
16. Dokusova OK, Krivoruchenko IV. [The effect of biotin on the level of cholesterol in the blood of patients with atherosclerosis and essential hyperlipidemia]. Kardiologiia 1972 Dec;12(12):113.
17. Fiume MZ; Cosmetic Ingredient Review Expert Panel. Final report on the safety assessment of biotin. Int J Toxicol 2001;20(Suppl 4):1-12.
18. Larrieta E, Velasco F, Vital P, López-Aceves T, Lazo-de-la-Vega-Monroy ML, Rojas A, et al. Pharmacological concentrations of biotin reduce serum triglycerides and the expression of lipogenic genes. Eur J Pharmacol 2010 Oct;644(1-3):263-268.
19. Vilches-Flores A, Tovar AR, Marin-Hernandez A, Rojas-Ochoa A, Fernandez-Mejia C. Biotin increases glucokinase expression via soluble guanylate cyclase/ protein kinase G, adenosine triphosphate production and autocrine action of insulin in pancreatic rat islets. J Nutr Biochem 2010 Jul;21(7):606-612.
20. Sugita Y, Shirakawa H, Sugimoto R, Furukawa Y, Komai M. Effect of biotin treatment on hepatic gene expression in streptozotocin-induced diabetic rats. Biosci Biotechnol Biochem 2008 May;72(5):1290-1298.
21. Koutsikos D, Fourtounas C, Kapetanaki A, Agroyannis B, Tzanatos H, Rammos G, et al. Oral glucose tolerance test after high-dose i.v. biotin administration in normoglucemic hemodialysis patients. Ren Fail 1996 Jan;18(1):131-137.
22. Revilla-Monsalve C, Zendejas-Ruiz I, Islas-Andrade S, Báez-Saldaña A, Palomino-Garibay MA, Hernández-Quiróz PM, et al. Biotin supplementation reduces plasma triacylglycerol and VLDL in type 2 diabetic patients and in nondiabetic subjects with hypertriglyceridemia. Biomed Pharmacother 2006 May;60(4):182-185.
23. Báez-Saldaña A, Zendejas-Ruiz I, Revilla-Monsalve C, Islas-Andrade S, Cárdenas A, Rojas-Ochoa A, et al. Effects of biotin on pyruvate carboxylase, acetyl-CoA carboxylase, propionyl-CoA carboxylase, and markers for glucose and lipid homeostasis in type 2 diabetic patients and nondiabetic subjects. Am J Clin Nutr 2004 Feb;79(2):238-243.
24. Fernandez-Mejia C, Lazo-de-la-Vega-Monroy ML. Biological effects of pharmacological concentrations of biotin. JEBCAM 2011;16:40-48.
25. Singer GM, Geohas J. The effect of chromium picolinate and biotin supplementation on glycemic control in poorly controlled patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized trial. Diabetes Technol Ther 2006 Dec;8(6):636-643.
26. Albarracin CA, Fuqua BC, Evans JL, Goldfine ID. Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes. Diabetes Metab Res Rev 2008 Jan-Feb;24(1):41-51.